Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06834594 · ClinicalTrials.gov registry record · Phase 4
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
A Phase 4 study of Turner Syndrome and Primary Ovarian Insufficiency (Poi), sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06834594 is a Phase 4 study of Turner Syndrome and Primary Ovarian Insufficiency (Poi) that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 40 participants, below the 516-participant average among 14 other Turner Syndrome trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06834594, a Phase 4 study of Turner Syndrome and Primary Ovarian Insufficiency (Poi), is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Conditions Studied
Interventions
- DRUG Micronized progesterone 200 MG
- DRUG Micronized Progesterone 100 MG
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06834594
The ClinicalTrials.gov registry entry for NCT06834594 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 516-participant average among 14 other Turner Syndrome trials with a reported enrollment target (92% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Turner Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Micronized progesterone 200 MG is the first listed.
NCT06834594 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06834594 about?
NCT06834594 is a clinical study titled "Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome". This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
What is the current status of trial NCT06834594?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2025-07-31. Estimated completion is 2026-07-31.
What conditions does trial NCT06834594 study?
This clinical trial studies the following conditions: Turner Syndrome, Primary Ovarian Insufficiency (Poi).
What interventions are being tested in trial NCT06834594?
The interventions under investigation include: Micronized progesterone 200 MG (DRUG), Micronized Progesterone 100 MG (DRUG).
Who is sponsoring clinical trial NCT06834594?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06834594 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Turner Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History of Noncirrhotic Portal Hypertension
RECRUITING
-
UTHealth Turner Syndrome Research Registry
RECRUITING
-
Vosoritide for Short Stature in Turner Syndrome
RECRUITING · Phase 2
-
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
RECRUITING
-
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
RECRUITING · Phase 2
-
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.